A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy
NCT01546623
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
TAP-144-SR(6M)
DRUG:
TAP-144-SR(3M)
Sponsor
Takeda